Vrudhula VM - Search Results

1

In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.

Svensson HP, Vrudhula VM, Emswiler JE, MacMaster JF, Cosand WL, Senter PD, Wallace PM. Svensson HP, et al. Among authors: vrudhula vm. Cancer Res. 1995 Jun 1;55(11):2357-65. Cancer Res. 1995. PMID: 7757987

2

Monoclonal antibody-beta-lactamase conjugates for the activation of a cephalosporin mustard prodrug.

Svensson HP, Kadow JF, Vrudhula VM, Wallace PM, Senter PD. Svensson HP, et al. Among authors: vrudhula vm. Bioconjug Chem. 1992 Mar-Apr;3(2):176-81. doi: 10.1021/bc00014a013. Bioconjug Chem. 1992. PMID: 1515470

3

Poly(ethylene glycol)-doxorubicin conjugates containing beta-lactamase-sensitive linkers.

Senter PD, Svensson HP, Schreiber GJ, Rodriguez JL, Vrudhula VM. Senter PD, et al. Among authors: vrudhula vm. Bioconjug Chem. 1995 Jul-Aug;6(4):389-94. doi: 10.1021/bc00034a008. Bioconjug Chem. 1995. PMID: 7578358

4

Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.

Kerr DE, Schreiber GJ, Vrudhula VM, Svensson HP, Hellström I, Hellström KE, Senter PD. Kerr DE, et al. Among authors: vrudhula vm. Cancer Res. 1995 Aug 15;55(16):3558-63. Cancer Res. 1995. PMID: 7627964

5

Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.

Vrudhula VM, Svensson HP, Senter PD. Vrudhula VM, et al. J Med Chem. 1995 Apr 14;38(8):1380-5. doi: 10.1021/jm00008a016. J Med Chem. 1995. PMID: 7731023

6

Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates.

Vrudhula VM, Svensson HP, Kennedy KA, Senter PD, Wallace PM. Vrudhula VM, et al. Bioconjug Chem. 1993 Sep-Oct;4(5):334-40. doi: 10.1021/bc00023a005. Bioconjug Chem. 1993. PMID: 8274516

7

Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugate.

Vrudhula VM, Senter PD, Fischer KJ, Wallace PM. Vrudhula VM, et al. J Med Chem. 1993 Apr 2;36(7):919-23. doi: 10.1021/jm00059a018. J Med Chem. 1993. PMID: 8464046

8

Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation.

Siemers NO, Kerr DE, Yarnold S, Stebbins MR, Vrudhula VM, Hellström I, Hellström KE, Senter PD. Siemers NO, et al. Among authors: vrudhula vm. Bioconjug Chem. 1997 Jul-Aug;8(4):510-9. doi: 10.1021/bc9700751. Bioconjug Chem. 1997. PMID: 9258449

9

Immunologically specific activation of a cephalosporin derivative of mitomycin C by monoclonal antibody beta-lactamase conjugates.

Vrudhula VM, Svensson HP, Senter PD. Vrudhula VM, et al. J Med Chem. 1997 Aug 15;40(17):2788-92. doi: 10.1021/jm970108y. J Med Chem. 1997. PMID: 9276025

10

Development and activities of a new melphalan prodrug designed for tumor-selective activation.

Kerr DE, Li Z, Siemers NO, Senter PD, Vrudhula VM. Kerr DE, et al. Among authors: vrudhula vm. Bioconjug Chem. 1998 Mar-Apr;9(2):255-9. doi: 10.1021/bc970163l. Bioconjug Chem. 1998. PMID: 9548542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters